Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daniel J. Albertson
Histone Deacetylase Inhibition Has Targeted Clinical Benefit in ARID1A Mutated Advanced Urothelial Carcinoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Mp71-12 Clinical Benefit of Platinum-Based Neoadjuvant Chemotherapy for Locally Advanced Upper Tract Urothelial Carcinoma
Journal of Urology
Urology
Molecular Sequelae of Histone Deacetylase Inhibition in Human Retinoblastoma Cell Lines: Clinical Implications
Investigative Ophthalmology and Visual Science
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Metabolism as a Key to Histone Deacetylase Inhibition
Critical Reviews in Biochemistry and Molecular Biology
Biochemistry
Molecular Biology
Histone Deacetylase Inhibition and Dietary Short-Chain Fatty Acids
ISRN Allergy
Histone Deacetylase 6 (HDAC6); Histone Deacetylase 8 (HDAC8)
Science-Business eXchange
Cabozantinib in Combination With Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
Molecular Cancer Therapeutics
Cancer Research
Oncology
Histone Deacetylase Inhibitors: Clinical Implications for Hematological Malignancies
Clinical Epigenetics
Genetics
Developmental Biology
Molecular Biology
A Novel Histone Deacetylase Inhibitor, CKD5, Has Potent Anti-Cancer Effects in Glioblastoma
Oncotarget
Oncology
Role of Sulforaphane on Histone Deacetylase Activity in Solid Ehrlich Carcinoma
Journal of Biosciences and Medicines